Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shunaoxin
- Development stage
- Phase 2
- Lead developer
- Tianjin Pharmaceutical Da Ren Tang Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shunaoxin is a Traditional Chinese Medicine (TCM) formulation, most commonly administered as dripping pills, developed by the Sixth Chinese Medicine Factory of Tianjin Zhongxin Pharmaceutical Group (now Tianjin Pharmaceutical Da Ren Tang Group). It is composed of concentrated extracts from *Ligusticum chuanxiong* and *Lycium barbarum*. The medication is primarily indicated for the treatment of cerebrovascular conditions such as cerebral infarction, cerebral arteriosclerosis, and associated symptoms including headache, dizziness, and memory loss. Its therapeutic effects are attributed to its ability to improve cerebral microcirculation, inhibit platelet aggregation, and provide neuroprotection against ischemic injury. Bioactive components like ligustrazine and ferulic acid contribute to its vasodilatory and antioxidant properties.
- Brand names
- Shunaoxin
- Other names
- Shunaoxin DiwanShunaoxin Dripping Pills
02
Targets
CaV (Voltage-gated calcium channel protein complex)
Beyond the preview
Go deeper on Shunaoxin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shunaoxin.